Skip to Main Content
Table 1

Patient demographics

Values represent the median value, with range in parentheses (unless stated otherwise).

Variable600 mg group350 mg/m2 group
Total no. of patients entered 26 47 
 Males 14 28 
 Females 12 19 
Age (yr) 57 (38–73) 53 (37–71) 
Length (m) 1.72 (1.55–1.86) 1.73 (1.55–1.92) 
Weight (kg) 71 (48–109) 73 (45–108) 
Body-surface area (m21.85 (1.45–2.31) 1.87 (1.40–2.36) 
Performance score 1 (0–1) 1 (0–1) 
Tumor types [N (%)]   
 SCLCa/NSCLC 13 (50) 2 (4) 
 Gastrointestinal 8 (31) 32 (68) 
 Miscellaneous 5 (19) 13 (28) 
Infusion duration (h) 1.50 (1.47–1.78) 1.50 (0.75–2.25) 
Variable600 mg group350 mg/m2 group
Total no. of patients entered 26 47 
 Males 14 28 
 Females 12 19 
Age (yr) 57 (38–73) 53 (37–71) 
Length (m) 1.72 (1.55–1.86) 1.73 (1.55–1.92) 
Weight (kg) 71 (48–109) 73 (45–108) 
Body-surface area (m21.85 (1.45–2.31) 1.87 (1.40–2.36) 
Performance score 1 (0–1) 1 (0–1) 
Tumor types [N (%)]   
 SCLCa/NSCLC 13 (50) 2 (4) 
 Gastrointestinal 8 (31) 32 (68) 
 Miscellaneous 5 (19) 13 (28) 
Infusion duration (h) 1.50 (1.47–1.78) 1.50 (0.75–2.25) 
a

SCLC, small cell lung cancer; NSCLC, non-small cell lung cancer.

Close Modal

or Create an Account

Close Modal
Close Modal